CASE STUDY / INTERNATIONAL SUBMISSIONS
Coordinating regional delivery for RNAi therapies
A rare disease portfolio required regional strategy and submission delivery through local partners.
An anonymised example from the principal consultant’s prior career experience, not a Darsh Pharmalink client engagement. Product and organisation names are withheld.
The challenge
Deliver marketing applications and lifecycle submissions across MENA markets while coordinating readiness and health authority responses.
The approach
Led regional strategy, worked with local partners on reliance and expedited pathways, and coordinated CMC input and response preparation.
The recorded outcome
Delivered more than 30 submissions in 19 months, including five new marketing applications and three approvals. Four of 13 variations received approval in under 15 days.
What this illustrates
Pathway assessment, partner coordination and submission readiness need to be managed together. These outcomes are specific to the products and markets involved.
This example illustrates a regulatory approach in a specific assignment. It does not predict outcomes for other products or jurisdictions.
A CLEAR NEXT STEP